Thank you for Subscribing to Med Tech Business Review Weekly Brief

Language in the Care of Patients with Inflammatory Bowel Disease: Who Failed?


As an advanced practice provider serving patients with inflammatory bowel disease, I am often struck by the language used within their healthcare journey.
Language and inference can inform patients' attitudes, perspectives, and the way they will interact with healthcare in the future. This language may seem insignificant, but the schema of our vernacular can inform not only the patient’s view of the care team but also their view of themselves and their journey alongside a chronic disease. This can be seen quite clearly when we discuss patients who have previously been exposed to medical therapies that have been ineffective at controlling their disease. A common case presentation can sound like, “Ms. Smith is a 26-year-old Crohn’s patient who has failed infliximab, ustekinumab, and adalimumab and presents today to review other therapy options.” How we discuss the ineffectiveness of medications can often leave the patient questioning if they failed medications or the medications failed them. Fine-tuning the language we use surrounding medical therapies can support the care of the patient as a whole person beyond their inflammatory burden. When we frame treatment experience as a failure, we risk impacting patients’ self-efficacy. The way we structure our sentences matters. There is a paucity of data evaluating the impact of language in the treatment of IBD; however, in my clinical experience, the use of negative language reinforces the negative stigma the patient may already feel about their disease process. Sometimes, this is a stigma the patient may not openly share with the care team. This can manifest as hesitance to try other advanced therapies or anxiety or depression related to their diagnosis and treatment.Language and inference can inform patient attitudes, perspectives and the way they will interact with healthcare in the future.